InsiderTrades

Form 4 for RGEN REPLIGEN CORP

Accepted 2023-03-06 00:00:00 ET · period of report 2023-03-02 · accession 0000899243-23-007191 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2023-03-06 2023-03-02+ RGEN Bylund James COO A - Grant $0.00 +8,973 18.1K +98% $0
D 2023-03-06 2023-03-03 RGEN Bylund James COO F - Tax $188.00 -210 17.9K -1% -$39.5K
D 2023-03-06 2023-03-02 RGEN Bylund James COO A - Grant $0.00 +8,644 8,644 New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2023-03-02 A A 8,348 $0.00 17,487 D — — (F1) Mr. Bylund was awarded 8,348 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest in equal annual instalments over a three-year period beginning on the first anniversary of the grant date. The restricted stock units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance.
2 Common Common Stock 2023-03-03 A A 625 $0.00 18,112 D — — (F2) Represents shares issued pursuant to a Performance Stock Unit ("PSU") award granted to the Issuer on January 1, 2022. The Compensation Committee authorized the issuance of the underlying shares based upon the Issuer's achievement of pre-established performance criteria set forth in the PSU award.
3 Common Common Stock 2023-03-03 F D 210 $188.00 17,902 D — — (F3) Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the settlement of the PSUs.
4 Derivative Stock Option (Right to Buy) 2023-03-02 A A 8,644 $0.00 8,644 D $180.48 · — to 2033-03-02 8,644 Common Stock (F4) One third of the stock options will vest and become exercisable annually on March 2, 2024, March 2, 2025 and March 2, 2026.